Close
Open Nav
2017 Investors

Below is a representative list of participating investment firms and sell side research analysts for the 2017 BIO Investor Forum.

11.2 Capital
5AM Ventures
6 Dimensions Capital
AbbVie, Inc.
Abingworth
Abingworth Management, Inc.
Acuris Partners
Agent Capital
Aisling Capital
Alignment Ventures
Altitude Life Science Ventures
Aphelion Capital
Aquilo Capital Management
Arch Venture Partners
Arix Bioscience
Asahi Kasei America
Asahi Kasei Pharma
Aspire Capital Partners
Asset Management Ventures
Astellas Innovation Management 
Astellas Venture Management
Astellas Venture Management LLC
ATEL Ventures
ATEM Capital
Bailard, Inc.
Band of Angels
Barclays
Bay City Capital
BDC Capital
Beijing Institute of Collaborative Innovation
BGI Venture
Biomark Capital
BioMed Ventures
BioPacific Investors
Bios Partners
BioSense Global
Biotech Alliances International
Bohe Angel Fund
Boson Capital Partners
Brace Pharma Capital
Brain Trust Accelerator Fund
Brandon Capital Partners
Bridge Bank
BridgeBio Pharma
Cagan Capital
Canaan Partners
Capital Family Office
Capital IP
Cato BioVentures
C-Bridge Capital
Chardan Capital Markets
Colorado Institute for Drug, Device and Diagnostic Development (CID4)
Complete Genomics, BGI
Crosswave Management
CRV
CSC Leasing
Deerfield Management
Defta Partners
Delphi Ventures
Dorset Capital LLC
Droia NV
Dynamk Capital
EcoR1 Capital
Endurant Capital
Eon
Excelyrate Capital
Finance Technology Leverage LLC
Fineman Financial
First Light Asset Management
Frameshift
Franklin Templeton
Frazier Healthcare Partners
FTL
FundRx
Gates Foundation Venture Capital
GeneWEAVE/Roche
Golden Seeds
Good  Health Capital
Granite Investment Partners
GreenSky Capital
H.I.G. BioHealth Partners
Hayfin Captial Management
Health Passion Fund
HealthCare Royalty Partners
Hemi Ventures
Hercules Capital
Hermed Capital
Horizon Technology Finance
Huret, Rothenberg and Co.
Illumina Ventures
Infinity2100
INKEF Capital
Innovation Endeavors
Innoviva
Innoviva, Inc.
IPF Partners
JAFCO
JDRF T1D Fund
Johnson & Johnson -  JJDC
Julz Co
Jump Capital
Juvenile Diabetes Research Foundation (JDRF)
KKR

Life Science Angels
Lincoln Park Capital
LMN Ventures
Logue, PC
Longitude Capital
Lumira Capital
LYFE Capital
Mackie Research Capital
Marathon Asset Management
MBL Venture Capital Co.
Medivate Partners 
Merck
Merieux Developpement
MidAtlantic Bio Angels
MidCap Financial
Militia Hill Ventures
Mission Bay Capital
Mithril Capital Management
Mitsui Global Investment
Mitsui Global Investoment
Moore Venture Partners
MP Healthcare Venture Management
MPM Capital
Mustang Ventures
MVM Partners
NanoDimension
Nasdaq
NEA
New Leaf Venture Partners
NF Trinity Capital
Novo Ventures (US)
Novo Ventures, US
OceanIQ Capital
OmniCyte
Opus Point Partners
Oresund Capital
Osage University Partners
Oxford Finance
Palo Alto Investors
Pappas Ventures
PharmaFund LLP
Pharmstandard Ventures
Pictet Asset Management
Pivotal - NFLS
Pivotal bioVenture Partners
PoC Capital
Portola Capital Partners
Premier Partners
Presidio Partners
Prevail Partners
Prime Capital
ProMéxico
Proteus Venture Partners
Qilu
Qiming U.S. Healthcare Fund
Quan Capital
Quark Venture
RBV Capital
Red Tailed Hawk Venture Partners
Remiges Ventures
Roche Venture Fund
Rosetta Capital 
RTP Capital
Samsara BioCapital
Sangel Capital Corp
Sanofi Ventures
Santen Pharmaceutical Co.
Satter Medical Technology Partnership
SDL Ventures
Shuster Capital
Silicon Valley Bank
SK Telecom
Slater Technology Fund
Small Business Administration, Office of Investment
Sofinnova
Solar Capital 
SternAegis Ventures
SunTrust Robinson Humphrey
Surveyor Capital
Taiho Ventures
Temasek
The Angels' Forum
Thiel Capital
TMX- TSX & TSXV
Tosoh USA, Inc.
TPG Biotech
Tsingyuan Ventures
Two Sigma Ventures
U.S. Angel Investors
V2M Capital
venBio Partners
Venrock
Versant Ventures
Vertex Ventures HC
VI Ventures
Virtus Inspire Ventures
Vivo Capital
W Global Capital/International Capital Management 
WBB Securities
Wellington Financial
WI Harper Group
WRF Capital
Xeraya Capital Life Venture
ZGC Capital

*As of 10/13/2017